Is autoimmune thyroid dysfunction a risk factor for gestational diabetes?;¿Existe mayor riesgo de diabetes gestacional en pacientes con disfunción tiroidea autoinmune?

Endocrinologia y Nutricion

Volumn 61, Issue 7, 2014, Pages 377-381

  Pascual Corrales, Eider ^a   Andrada, Patricia ^a   Aubá, María ^a   Ruiz Zambrana, Álvaro ^a   Guillén Grima, Francisco ^a   Salvador, Javier ^a   Escalada, Javier ^a   Galofré, Juan C ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Autoimmunity; Autoinmunidad; Diabetes gestacional; Gestational diabetes; Hipotiroidismo; Hypothyroidism

Indexed keywords

THYROID ANTIBODY; THYROTROPIN;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOTHYROIDISM; LOGISTIC REGRESSION ANALYSIS; PATIENT MONITORING; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; COMPLICATION; DIABETES, GESTATIONAL; IMMUNOLOGY; PREGNANCY;

ADULT; AUTOIMMUNE DISEASES; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPOTHYROIDISM; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84905036276     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2014.01.009     Document Type: Article

References (30)

1. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011, 34(Suppl 1):S62-S69. American Diabetes Association.
2. King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 1998, 21(Suppl 2):B9-B13.
3. Corcoy R., Cerqueira M.L., Codina M., Ordóñez J., de Leiva A., Cabero L. Diagnóstico de la diabetes gestacional: importancia del screening rutinario y utilidad relativa de los factores de riesgo. Av Diabetol 1988, 1:90-94.
4. Díez J.J., Grande C., Pallardo L.F., de la Morena M.L., Ibars M.T. Detección de la diabetes con la prueba de 50g de glucosa: prevalencia y relación de factores de riesgo. Med Clin (Barc) 1989, 93:41-45.
5. Goday A., Serrano-Ríos M. Epidemiología de la diabetes mellitus en España. Revisión crítica y nuevas perspectivas. Med Clin (Barc) 1994, 102:306-615.
6. Ricart W., Bach C., Fernández-Real J.M., Biarnés J., Sabrià J. Impacto de un cribado selectivo de la diabetes gestacional en una población española. Med Clin (Barc) 1999, 113:331-333.
7. Festa A., Hanley A.J., Tracy R.P., D'Agostino R., Haffner S.M. Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 2003, 108:1822-1830.
8. Azriel S., Garcia Burguillo A., Camaño I., Montañez D. Relationship between perinatal outcomes and thyroid-peroxidase antibodies (TPO) in a cohort of pregnant women with gestational diabetes (GD). Diabetologia 2010, 53:S438.
9. Matejková-Behanová M., Zamrazil V., Vondra K., Vrbíková J., Kucera P., Hill M., et al. Autoimmune thyroiditis in non-obese subjects with initial diagnosis of type 2 diabetes mellitus. J Endocrinol Invest 2002, 25:779-784.
10. Janssen O.E., Mehlmauer N., Hahn S., Offner A.H., Gärtner R. High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome. Eur J Endocrinol 2004, 150:363-369.
11. Drugarin D., Negru S., Koreck A., Zosin I., Cristea C. The pattern of a T(H)1 cytokine in autoimmune thyroiditis. Immunol Lett 2000, 71:73-77.
12. Winer D.A., Winer S., Chng M.H., Shen L., Engleman E.G. B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance. Cell Mol Life Sci 2013, 15.
13. Christ-Crain M., Meier C., Guglielmetti M., Huber P.R., Riesen W., Staub J.J., et al. Elevated C-reactive protein and homocysteine values: Cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis 2003, 166:379-386.
14. Chase H.P., Cooper S., Osberg I., Stene L.C., Barriga K., Norris J., et al. Elevated C-reactive protein levels in the development of type 1 diabetes. Diabetes 2004, 53:2569-2573.
15. Qiu C., Sorensen T.K., Luthy D.A., Williams M.A. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol 2004, 18:377-384.
16. Wolf M., Sandler L., Hsu K., Vossen-Smirnakis K., Ecker J.L., Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003, 26:819-824.
17. Galofré J.C., Pujante P., Abreu C., Santos S., Guillen-Grima F., Frühbeck G., et al. Relationship between thyroid-stimulating hormone and insulin in euthyroid obese men. Ann Nutr Metab 2008, 53:188-194.
18. Maratou E., Hadjidakis D.J., Kollias A., Tsegka K., Peppa M., Alevizaki M., et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009, 160:785-790.
19. Dimitriadis G., Mitrou P., Lambadiari V., Boutati E., Maratou E., Koukkou E., et al. Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: The importance of blood flow. J Clin Endocrinol Metab 2008, 93:2413-2415.
20. Stagnaro-Green A., Abalovich M., Alexander E., Azizi F., Mestman J., Negro R., et al. American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011, 21:1081-1125.
21. a edición). Av Diabetol 2006, 22:73-87. Grupo Español de Diabetes y Embarazo (GEDE): Sociedad Española de Diabetes (SED). Sociedad Española de Ginecología y Obstetricia (SEGO) y Asociación Española de Pediatría (Sección de Neonatología).
22. Hornnes P.J., Rasmussen N., Hegedüs L., Kühl C., Bottazzo G.F. Glucose tolerance and incidence of pancreatic islet cell antibodies in pregnancy in women with thyroid autoantibodies. Horm Metab Res 1991, 23:122-125.
23. Olivieri A., Valensise H., Magnani F., Medda E., De Angelis S., D'Archivio M., et al. High frequency of antithyroid autoantibodies in pregnant women at increased risk of gestational diabetes mellitus. Eur J Endocrinol 2000, 143:741-747.
24. Vitacolonna E., Lapolla A., Di Nenno B., Passante A., Bucci I., Giuliani C., et al. Gestational diabetes and thyroid autoimmunity. Int J Endocrinol 2012, 2012:867415.
25. Karakosta P., Alegakis D., Georgiou V., Roumeliotaki T., Fthenou E., Vassilaki M., et al. Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes. J Clin Endocrinol Metab 2012, 97:4464-4472.
26. Männistö T., Vääräsmäki M., Pouta A., Hartikainen A.L., Ruokonen A., Surcel H.M., et al. Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life. J Clin Endocrinol Metab 2010, 95:1084-1094.
27. Sahu M.T., Das V., Mittal S., Agarwal A., Sahu M. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 2010, 281:215-220.
28. Montaner P., Juan L., Campos R., Gil L., Corcoy R. Is thyroid autoimmunity associated with gestational diabetes mellitus?. Metabolism 2008, 57:522-525.
29. Di Cianni G., Volpe L., Lencioni C., Miccoli R., Cuccuru I., Ghio A., et al. Prevalence and risk factors for gestational diabetes assessed by universal screening. Diabetes Res Clin Pract 2003, 62:131-137.
30. Dyck R., Klomp H., Tan L.K., Turnell R.W., Boctor M.A. A comparison of rates, risk factors, and outcomes of gestational diabetes between aboriginal and non-aboriginal women in the Saskatoon health district. Diabetes Care 2002, 25:487-493.